GRCL

MKT CAP:$990M

Gracell Biotechnologies Inc.

Market Cap

$990M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Healthcare·Biotechnology·🇺🇸·NASDAQ

Stock Price

$519.90+$134.90 (+35.04%)

Jun 5, 2026

52W High $610.9552W Low $306.85

Company Details

Gracell Biotechnologies Inc., a clinical-stage biopharmaceutical company, primarily discovers and develops cell therapies for the treatment of cancer in the People's Republic of China. Its lead product candidates include GC012F, a FasTCAR-e...

CEO

—

IPO Date

Jan 8, 2021

Website

www.gracellbio.com

Key Metrics TTM (CNY)

Revenue

¥0

- YoY

Net Income

-¥497M

EPS (Diluted)

Free Cash Flow

Revenue / Share

¥0.00

Gross Margin

Operating Margin

Net Margin

FCF Margin

P/S

P/E

Earnings Reports

FY 2023

Dec 31, 2023

¥0

Q3 2023

Nov 13, 2023

¥0

Q2 2023

Aug 14, 2023

¥0

Q1 2023

May 15, 2023

¥0

FY 2022

Mar 13, 2023

¥0-100.0%

Revenue & Profitability (CNY)

Operating Cash Flow (CNY)

Capital Expenditures (CNY)

CapEx

OpEx vs Revenue Growth (YoY)

OpEx Breakdown (CNY)

War Chest (CNY)

Shares Outstanding